Review




Structured Review

Sun Nuclear Corporation arccheck phantom model 1220
Arccheck Phantom Model 1220, supplied by Sun Nuclear Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arccheck+phantom+model+1220/pm39968949-45-18-22?v=Sun+Nuclear+Corporation
Average 90 stars, based on 1 article reviews
arccheck phantom model 1220 - by Bioz Stars, 2026-07
90/100 stars

Images



Similar Products

90
Sun Nuclear Corporation arccheck phantom model 1220
Arccheck Phantom Model 1220, supplied by Sun Nuclear Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arccheck+phantom+model+1220/pm39968949-45-18-22?v=Sun+Nuclear+Corporation
Average 90 stars, based on 1 article reviews
arccheck phantom model 1220 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Sun Nuclear Corporation 3d diode array arccheck phantom model 1220
Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs <t> ArcCHECK </t> for head‐and‐neck cancer patients.
3d Diode Array Arccheck Phantom Model 1220, supplied by Sun Nuclear Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arccheck+phantom+model+1220/pmc07700942-120-8-15?v=Sun+Nuclear+Corporation
Average 90 stars, based on 1 article reviews
3d diode array arccheck phantom model 1220 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs  ArcCHECK  for head‐and‐neck cancer patients.

Journal: Journal of Applied Clinical Medical Physics

Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

doi: 10.1002/acm2.13036

Figure Lengend Snippet: Percentage dosimetric differences between treatment planning system (TPS) vs M3D, TPS vs MFX, and TPS vs ArcCHECK for head‐and‐neck cancer patients.

Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).

Techniques:

Percentage dosimetric differences between TPS vs M3D, TPS vs MFX, and TPS vs  ArcCHECK  for chest cancer patients.

Journal: Journal of Applied Clinical Medical Physics

Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

doi: 10.1002/acm2.13036

Figure Lengend Snippet: Percentage dosimetric differences between TPS vs M3D, TPS vs MFX, and TPS vs ArcCHECK for chest cancer patients.

Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).

Techniques:

Percentage dosimetric differences between TPS vsM3D, TPS vs MFX, and TPS vs  ArcCHECK  for abdomen cancer patients.

Journal: Journal of Applied Clinical Medical Physics

Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

doi: 10.1002/acm2.13036

Figure Lengend Snippet: Percentage dosimetric differences between TPS vsM3D, TPS vs MFX, and TPS vs ArcCHECK for abdomen cancer patients.

Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).

Techniques:

Percentage gamma pass rates of individual volume gamma indices and global gamma indices for three sites patients at 3%/3 mm criterion.

Journal: Journal of Applied Clinical Medical Physics

Article Title: Cross verification of independent dose recalculation, log files based, and phantom measurement‐based pretreatment quality assurance for volumetric modulated arc therapy

doi: 10.1002/acm2.13036

Figure Lengend Snippet: Percentage gamma pass rates of individual volume gamma indices and global gamma indices for three sites patients at 3%/3 mm criterion.

Article Snippet: Phantom measurement‐based QA was carried out by a 3D diode array ArcCHECK phantom (Model 1220; Sun Nuclear Corporation, USA).

Techniques: